Literature DB >> 12640202

Psychological distress and progression to AIDS in a cohort of injection drug users.

Elizabeth T Golub1, Jacquie A Astemborski, Donald R Hoover, James C Anthony, David Vlahov, Steffanie A Strathdee.   

Abstract

OBJECTIVE: We investigated whether distress was independently associated with more rapid progression to AIDS among HIV-infected injection drug users (IDUs).
DESIGN: A cohort study of IDUs in Baltimore followed from 1988 through 1999. A total of 451 IDUs met the eligibility criteria of being HIV-seropositive but AIDS-free at baseline.
METHODS: We used Cox proportional hazards models to investigate progression to AIDS within 2 years of baseline, controlling for CD4 lymphocyte count, HIV-1 viral load, and oral thrush.
RESULTS: Of the 451 participants, 76.3% were male and 95.8% were African-American; the median age at enrollment was 34 years. The cumulative incidence of AIDS within 2 years of baseline was 7.1%. In multiple regression analysis, distress was associated with more rapid time to AIDS (adjusted relative hazard [RH] = 2.39; 95% CI: 1.16-4.90). The strongest association was observed among IDUs with the lowest (<200 x 10 /L) CD4 counts (adjusted RH = 4.94; 95% CI: 1.30-18.77).
CONCLUSIONS: Psychological distress was independently associated with shorter time to AIDS among HIV-infected IDUs, especially among those with the lowest CD4 cell counts, but was not predictive of mortality in this cohort. Further study of the effects of psychological distress on AIDS progression within this population is warranted.

Entities:  

Mesh:

Year:  2003        PMID: 12640202     DOI: 10.1097/00126334-200304010-00013

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  9 in total

1.  Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania.

Authors:  Gretchen Antelman; Sylvia Kaaya; Ruilan Wei; Jessie Mbwambo; Gernard I Msamanga; Wafaie W Fawzi; Mary C Smith Fawzi
Journal:  J Acquir Immune Defic Syndr       Date:  2007-04-01       Impact factor: 3.731

2.  Family mechanisms of structural ecosystems therapy for HIV-seropositive women in drug recovery.

Authors:  Victoria B Mitrani; Brian E McCabe; Myron J Burns; Daniel J Feaster
Journal:  Health Psychol       Date:  2012-06-18       Impact factor: 4.267

3.  Social Vulnerabilities and Reported Discrimination in Health Care Among HIV-Positive Medical Case Management Clients in New York City.

Authors:  Katherine Penrose; McKaylee Robertson; Denis Nash; Graham Harriman; Mary Irvine
Journal:  Stigma Health       Date:  2019-08-12

Review 4.  Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals.

Authors:  Gregory M Lucas
Journal:  Life Sci       Date:  2010-10-01       Impact factor: 5.037

Review 5.  Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review.

Authors:  Michael-John S Milloy; Brandon D L Marshall; Thomas Kerr; Jane Buxton; Tim Rhodes; Julio Montaner; Evan Wood
Journal:  AIDS       Date:  2012-06-01       Impact factor: 4.177

6.  A multilevel mediation model of stress and coping for women with HIV and their families.

Authors:  Ahnalee M Brincks; Daniel J Feaster; Victoria B Mitrani
Journal:  Fam Process       Date:  2010-12

7.  Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women.

Authors:  Judith A Cook; Dennis D Grey; Jane K Burke-Miller; Mardge H Cohen; David Vlahov; Farzana Kapadia; Tracey E Wilson; Robert Cook; Rebecca M Schwartz; Elizabeth T Golub; Kathryn Anastos; Claudia Ponath; Lakshmi Goparaju; Alexandra M Levine
Journal:  Drug Alcohol Depend       Date:  2007-02-08       Impact factor: 4.492

8.  Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject Drugs.

Authors:  Elizabeth Buckingham; Ezra Schrage; Francine Cournos
Journal:  Adv Prev Med       Date:  2013-01-17

9.  Frequency of and Risk Factors for Depression among Participants in the Swiss HIV Cohort Study (SHCS).

Authors:  Alexia Anagnostopoulos; Bruno Ledergerber; René Jaccard; Susy Ann Shaw; Marcel Stoeckle; Enos Bernasconi; Jürgen Barth; Alexandra Calmy; Alexandre Berney; Josef Jenewein; Rainer Weber
Journal:  PLoS One       Date:  2015-10-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.